Incidence of cytogenetic aberrations in two B lineage subpopulations in multiple myeloma patients analyzed by combination of whole-genome profiling and FISH.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neoplasma (Bratislava)

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 24195508
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-Resolution Genomic Profiling of Chronic Lymphocytic Leukemia Reveals New Recurrent Genomic Alterations

  2014cited by this paper
• Gain(1)(q21) is an unfavorable genetic prognostic factor for patients with relapsed multiple myeloma treated with thalidomide but not for those treated with bortezomib.

  2013cited by this paper
• Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders

  2012cited by this paper
• High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations.

  2012cited by this paper
• Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial

  2012cited by this paper
• Phenotypic Detection of Clonotypic B Cells in Multiple Myeloma by Specific Immunoglobulin Ligands Reveals their Rarity in Multiple Myeloma

  2012cited by this paper
• In multiple myeloma, bone-marrow lymphocytes harboring the same chromosomal abnormalities as autologous plasma cells predict poor survival

  2012cited by this paper
• Stemness of B-cell Progenitors in Multiple Myeloma Bone Marrow

  2012cited by this paper
• Oligonucleotide-based array CGH as a diagnostic tool in multiple myeloma patients.

  2011cited by this paper
• Evaluating the clonal hierarchy in light-chain multiple myeloma: implications against the myeloma stem cell hypothesis

  2011cited by this paper
• MicroRNAs 15a/16-1 function as tumor suppressor genes in multiple myeloma.

  2010cited by this paper
• The search for multiple myeloma stem cells: the long and winding road.

  2010cited by this paper
• Optimization of immunomagnetic selection of myeloma cells from bone marrow using magnetic activated cell sorting

  2010cited by this paper
• Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders

  2010cited by this paper
• Cancer stem cells: controversies in multiple myeloma

  2009cited by this paper
• Cancer stem cells in multiple myeloma.

  2009cited by this paper
• Multiple myeloma cancer stem cells.

  2008cited by this paper
• CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms.

  2007cited by this paper
• Efficient Calculation of Interval Scores for DNA Copy Number Data Analysis

  2005influential reference
• Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors.

  2005cited by this paper
• Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.

  2004cited by this paper
• Intraclonal homogeneity of clonotypic immunoglobulin M and diversity of nonclinical post-switch isotypes in multiple myeloma: insights into the evolution of the myeloma clone.

  2002cited by this paper
• Multiple myeloma: evolving genetic events and host interactions

  2002cited by this paper
• Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance

  2002cited by this paper
• Persistent preswitch clonotypic myeloma cells correlate with decreased survival: evidence for isotype switching within the myeloma clone.

  2001cited by this paper
• In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease.

  2000cited by this paper
• High numbers of clonal CD19+ cells in the peripheral blood of a patient with multiple myeloma

  1999cited by this paper
• A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction.

  1998cited by this paper
• Tumor-specific aneuploidy not detected in CD19+ B-lymphoid cells from myeloma patients in a multidimensional flow cytometric analysis.

  1996cited by this paper
• Circulating clonotypic B cells in the biology of multiple myeloma: speculations on the origin of myeloma.

  1996cited by this paper
• Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44.

  1996cited by this paper
• Multiple myeloma clones are derived from a cell late in B lymphoid development.

  1995cited by this paper
• Evidence that the clonogenic cell in multiple myeloma originates from a pre‐switched but somatically mutated B cell

  1994cited by this paper
• The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell

  1993cited by this paper
• Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas

  1993cited by this paper
• Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry

  1990cited by this paper
• Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry.

  1990cited by this paper

• Clonal cytogenetics changes in progression of multiple myelomato extramedullary relapse and plasmocellular leukemia: a casereport

  2016cites this paper
• Genome-wide screening of DNA copy number alterations in cervical carcinoma patients with CGH+SNP microarrays and HPV-FISH.

  2014cites this paper